These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 18160011)

  • 1. Biological and genetic evolution of HIV type 1 in two siblings with different patterns of disease progression.
    Ripamonti C; Leitner T; Laurén A; Karlsson I; Pastore A; Cavarelli M; Antonsson L; Plebani A; Fenyö EM; Scarlatti G
    AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1531-40. PubMed ID: 18160011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV biological variability unveiled: frequent isolations and chimeric receptors reveal unprecedented variation of coreceptor use.
    Karlsson I; Antonsson L; Shi Y; Karlsson A; Albert J; Leitner T; Olde B; Owman C; Fenyö EM
    AIDS; 2003 Dec; 17(18):2561-9. PubMed ID: 14685050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies.
    Burke B; Derby NR; Kraft Z; Saunders CJ; Dai C; Llewellyn N; Zharkikh I; Vojtech L; Zhu T; Srivastava IK; Barnett SW; Stamatatos L
    Virology; 2006 Nov; 355(2):138-51. PubMed ID: 16920175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.
    Sabri F; Tresoldi E; Di Stefano M; Polo S; Monaco MC; Verani A; Fiore JR; Lusso P; Major E; Chiodi F; Scarlatti G
    Virology; 1999 Nov; 264(2):370-84. PubMed ID: 10562499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the HIV type 1 envelope gene from non-subtype B HIV type 1-infected children in Kenya.
    Lwembe R; Lihana RW; Ochieng' W; Panikulam A; Mongoina CO; Palakudy T; de Koning H; Ishizaki A; Kageyama S; Musoke R; Owens M; Songok EM; Okoth FA; Ichimura H
    AIDS Res Hum Retroviruses; 2009 Feb; 25(2):141-7. PubMed ID: 19108688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using Variants.
    Lin N; Gonzalez OA; Registre L; Becerril C; Etemad B; Lu H; Wu X; Lockman S; Essex M; Moyo S; Kuritzkes DR; Sagar M
    EBioMedicine; 2016 Jun; 8():237-247. PubMed ID: 27428434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
    Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
    Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of R5 and X4 HIV variants in antiretroviral treatment experienced patients with virologic failure.
    Ferrer P; Tello M; Montecinos L; Tordecilla R; Rodríguez C; Beltrán C; Guzmán MA; Ferrés M; Pérez CM; Afani A
    J Clin Virol; 2014 Jul; 60(3):290-4. PubMed ID: 24793966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected coreceptor usage of primary human immunodeficiency virus type 1 isolates from viremic patients under highly active antiretroviral therapy.
    Holtkamp N; Otteken A; Findhammer S; Miller V; Kurth R; Werner A
    J Infect Dis; 2000 Feb; 181(2):513-21. PubMed ID: 10669334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coreceptor change appears after immune deficiency is established in children infected with different HIV-1 subtypes.
    Casper C; Navér L; Clevestig P; Belfrage E; Leitner T; Albert J; Lindgren S; Ottenblad C; Bohlin AB; Fenyö EM; Ehrnst A
    AIDS Res Hum Retroviruses; 2002 Mar; 18(5):343-52. PubMed ID: 11897036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
    Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
    J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coreceptor usage and RANTES sensitivity of non-syncytium-inducing HIV-1 isolates obtained from patients with AIDS.
    Jansson M; Backström E; Björndal A; Holmberg V; Rossi P; Fenyö EM; Popovic M; Albert J; Wigzell H
    J Hum Virol; 1999; 2(6):325-38. PubMed ID: 10774549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
    AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotypic and phenotypic correlates of the HIV Type 1 env gene evolution in infected children with discordant response to antiretroviral therapy.
    Bagnarelli P; Vecchi M; Burighel N; Bellanova D; Menzo S; Clementi M; De Rossi A
    AIDS Res Hum Retroviruses; 2004 Dec; 20(12):1306-13. PubMed ID: 15650423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular tropisms and co-receptor usage of HIV-1 isolates from vertically infected children with neurological abnormalities and rapid disease progression.
    McCarthy M; He J; Auger D; Geffin R; Woodson C; Hutto C; Wood C; Scott G
    J Med Virol; 2002 May; 67(1):1-8. PubMed ID: 11920811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and phenotypic features of blood and genital viral populations of clinically asymptomatic and antiretroviral-treatment-naive clade a human immunodeficiency virus type 1-infected women.
    Andreoletti L; Skrabal K; Perrin V; Chomont N; Saragosti S; Gresenguet G; Moret H; Jacques J; Longo Jde D; Matta M; Mammano F; Belec L
    J Clin Microbiol; 2007 Jun; 45(6):1838-42. PubMed ID: 17460054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-receptor switch during HAART is independent of virological success.
    Saracino A; Monno L; Cibelli DC; Punzi G; Brindicci G; Ladisa N; Tartaglia A; Lagioia A; Angarano G
    J Med Virol; 2009 Dec; 81(12):2036-44. PubMed ID: 19856465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 co-receptor usage based on V3 loop sequence analysis: preferential suppression of CXCR4 virus post HAART?
    Jiao Y; Wang P; Zhang H; Zhang T; Zhang Y; Zhu H; Wu H
    Immunol Invest; 2011; 40(6):597-613. PubMed ID: 21513481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
    Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
    Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of HIV-1 quasispecies and coreceptor use in cell reservoirs of patients on suppressive antiretroviral therapy.
    Raymond S; Saliou A; Delobel P; Cazabat M; Pasquier C; Jeanne N; Sauné K; Massip P; Marchou B; Izopet J
    J Antimicrob Chemother; 2014 Sep; 69(9):2527-30. PubMed ID: 24840625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.